28th Annual North American Cystic Fibrosis Conference

S01: CFTR: Potentiator Action: Not an Open & Shut Case

Oct 9, 2014 2:00pm ‐ Oct 9, 2014 3:50pm

Standard: $49.99


This session will review our understanding of potentiator mechanism of action and compare the effects that potentiators, such as ivacaftor (VX-770), have on different mutant CFTR proteins. Conclusions that allow for determination of candidates for current potentiator therapies will be drawn. Differences in mutant and wild-type CFTR thermal sensitivity will be discussed. Finally, the impact of potentiators on CFTR correction will be addressed.


You must be logged in and own this session in order to post comments.